Dexco Statistics

Total Valuation

Dexco has a market cap or net worth of BRL 6.37 billion. The enterprise value is 12.29 billion.

Market Cap	6.37B
Enterprise Value	12.29B

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Dexco has 808.36 million shares outstanding. The number of shares has decreased by -0.76% in one year.

Shares Outstanding	808.36M
Shares Change (YoY)	-0.76%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	20.71%
Owned by Institutions (%)	26.43%
Float	306.18M

Valuation Ratios

The trailing PE ratio is 11.79 and the forward PE ratio is 20.09. Dexco's PEG ratio is 2.27.

PE Ratio	11.79
Forward PE	20.09
PS Ratio	0.83
PB Ratio	0.97
P/FCF Ratio	187.12
PEG Ratio	2.27

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.29, with an EV/FCF ratio of 361.16.

EV / Earnings	22.69
EV / Sales	1.61
EV / EBITDA	7.29
EV / EBIT	22.91
EV / FCF	361.16

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 119.71.

Current Ratio	1.51
Quick Ratio	1.08
Debt / Equity	119.71
Debt / EBITDA	5.04
Debt / FCF	235.42
Interest Coverage	0.57

Financial Efficiency

Return on equity (ROE) is 8.72% and return on invested capital (ROIC) is 1.99%.

Return on Equity (ROE)	8.72%
Return on Assets (ROA)	1.59%
Return on Capital (ROIC)	1.99%
Revenue Per Employee	537,603
Profits Per Employee	38,083
Employee Count	14,228
Asset Turnover	0.44
Inventory Turnover	3.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.94% in the last 52 weeks. The beta is 0.90, so Dexco's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	+1.94%
50-Day Moving Average	7.53
200-Day Moving Average	7.54
Relative Strength Index (RSI)	50.41
Average Volume (20 Days)	3,313,810

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dexco had revenue of BRL 7.65 billion and earned 541.84 million in profits. Earnings per share was 0.67.

Revenue	7.65B
Gross Profit	1.80B
Operating Income	439.78M
Pretax Income	529.40M
Net Income	541.84M
EBITDA	1.52B
EBIT	439.78M
Earnings Per Share (EPS)	0.67

Full Income Statement

Balance Sheet

The company has 2.07 billion in cash and 8.01 billion in debt, giving a net cash position of -5.80 billion or -7.18 per share.

Cash & Cash Equivalents	2.07B
Total Debt	8.01B
Net Cash	-5.80B
Net Cash Per Share	-7.18
Equity (Book Value)	6.69B
Book Value Per Share	8.13
Working Capital	1.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.44 billion and capital expenditures -1.41 billion, giving a free cash flow of 34.04 million.

Operating Cash Flow	1.44B
Capital Expenditures	-1.41B
Free Cash Flow	34.04M
FCF Per Share	0.04

Full Cash Flow Statement

Margins

Gross margin is 23.57%, with operating and profit margins of 5.75% and 7.08%.

Gross Margin	23.57%
Operating Margin	5.75%
Pretax Margin	6.92%
Profit Margin	7.08%
EBITDA Margin	19.86%
EBIT Margin	5.75%
FCF Margin	0.45%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 2.73%.

Dividend Per Share	0.22
Dividend Yield	2.73%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.01%
Buyback Yield	0.76%
Shareholder Yield	3.50%
Earnings Yield	8.48%
FCF Yield	0.53%

Dividend Details

Stock Splits

The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 21, 2022
Split Type	Forward
Split Ratio	1.1